BRCA2 mutations in primary breast and ovarian cancers

Nature Genetics

Volumn 13, Issue 2, 1996, Pages 238-240

  Lancaster, Johnathan M ^a   Wooster, Richard ^b   Mangion, Jonathon ^b   Phelan, Catherine M ^c,d,e   Cochran, Charles ^a   Gumbs, Curtis ^e   Seal, Sheila ^b   Barfoot, Rita ^b   Collins, Nadine ^b   Bignell, Graham ^b   Patel, Sandeep ^b   Hamoudi, Rifat ^b   Larsson, Catharine ^c   Wiseman, Roger W ^a   Berchuck, Andrew ^e   Iglehart, J Dirk ^e   Marks, Jeffrey R ^e   Ashworth, Alan ^b   Stratton, Michael R ^b   Futreal, P Andrew ^e  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; GENE ISOLATION; GENE LOCUS; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AGED; BASE SEQUENCE; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA PRIMERS; FEMALE; GENETIC MARKERS; HETEROZYGOTE; HUMANS; LYMPHOCYTES; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; RETINOBLASTOMA PROTEIN; SEQUENCE DELETION; TRANSCRIPTION FACTORS;

EID: 9044225148     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0696-238     Document Type: Article

References (13)

1. Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 769-792 (1995).
2. Lundberg, C. et al. Loss of heterozygosity in human ductal breast tumours indicates a recessive mutation on chromosome 13. Proc. Natl. Acad. Sci. USA 84, 2372-2376 (1987)
3. Kim, T.M. et al. Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian eptithelial tumors and is associated with normal retinoblastoma expression. Cancer Res. 54, 605-609 (1994).
4. Collins, N. et al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene chromosome 13q12-13. Oncogene 10, 1673-1675 (1995).
5. Cleton-Jansen, A.M. et al. Loss of heterozygosity in sporadic breast tumors at the BRCA2 locus on chromosome 13q12-13. Br. J. Cancer 72, 1241-1244 (1995).
6. Phelan, C.M. et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nature Genet. 13, 120-122 (1996).
7. Futreal, P.A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120-122 (1994).
8. Merajver, S.A. et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet. 9, 439-443 (1995).
9. Hosking, L. et al. A somatic BRCA1 mutation in an ovarian tumour. Nature Genet. 9, 343-344 (1995).
10. Takahashi, H. et al. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res. 55, 2998-3002 (1995).
11. Kerangueven, F. et al. Patterns of loss of heterzygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors. Genes Chrom. Cancer 13, 291-294 (1995).
12. Chen, Y, et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270, 789-791, (1995).
13. Thompson, M.E., Jensen, R.A., Obermiller, P.S., Page, D.L. & Holt, J.T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet. 9, 444-450 (1995).